Boston University Medical Center Leadership Program in Vascular Medicine

波士顿大学医学中心血管医学领导力项目

• 批准号: 8527821
• 负责人: Robert Thomas Eberhardt
• 金额: $ 64.89万
• 依托单位: BOSTON MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-02-08 至 2015-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8527821
• 关键词: Academic Medical Centers; Blood Vessels; Boston; Caring; Clinical; Clinical Trials; Competence; Discipline; Disease; Educational Curriculum; Elements; Ensure; Environment; Evaluation; Fostering; Funding; Future; Goals; Growth; Individual; Investigation; Knowledge; Leadership; Master' s Degree; Medicine; Mentors; Outcome; Physicians; Positioning Attribute; Process; Public Health Schools; Publications; Research; Research Design; Research Personnel; Research Project Grants; Research Training; Resources; Rotation; Scientist; Specialist; Training; United States; Universities; Vascular Diseases; abstracting; career; design; experience; insight; meetings; next generation; programs; skills; success; symposium

DESCRIPTION (provided by applicant): The evolving discipline of vascular medicine encompasses the evaluation and management of a diverse, yet prevalent, group of disorders, many of which denote a serious outcome. We endorse the principle that there are insufficient trained specialists in the United States to meet the growing demands of this important field.To foster the growth of future Vascular Medicine Specialists, we appreciate this initiative to train new individuals in the conduct of clinical vascular-related research and thus serve as the next generation of academic leaders. The Boston University Leadership Program in Vascular Medicine will be particularly well suited to the goal of training physicians to pursue an academic career in vascular medicine. The well rounded clinical curriculum utilizes the strengths of a multi-disciplinary approach (including rotations, vascular lab exposures, and didactics), designed to assure that trainees acquire the knowledge and clinical experience required to care for the spectrum of vascular disorders. The clinical program is sub-divided into two tracts; one designed for general vascular medicine training, and the other tailored towards the endovascular specialist. The research component will ensure that these clinicians develop the skills and competence to conduct independent clinical investigations. Individual elements of the research training include a didactic program of seminars and conferences, completion of a Masters Degree Program at the Boston University School of Public Health, and a supervised research project. This mentored research project will be conducted under the guidance of a senior and highly experienced researcher in a vascular related field. We believe that Boston University Medical Center serves as an excellent and rich environment to allow the training of future clinical scientists in vascular medicine, drawing on the strengths of many established and prominent investigators and programs in the field. We have integrated this approach, making use of our shared facilities and resources. We intend our program to promote insight into all steps of the research process, ranging from study design and funding to analysis and publication. Upon completion of the program we expect the trainee to demonstrate expertise in the clinical aspects of vascular disease care, and be well positioned to conduct independently funded vascular investigations, both attributes considered essential to the success of this program. (End of Abstract)

描述（由申请人提供）： 不断发展的血管医学学科涵盖了对多种但普遍存在的疾病的评估和管理，其中许多疾病会产生严重的后果。我们赞同这样的原则：美国没有足够的训练有素的专家来满足这一重要领域不断增长的需求。为了促进未来血管医学专家的成长，我们赞赏这一举措，旨在培训进行临床血管相关研究的新人，从而成为下一代学术领导者。波士顿大学血管医学领导力计划特别适合培训医生从事血管医学学术职业的目标。全面的临床课程利用多学科方法的优势（包括轮换、血管实验室暴露和教学），旨在确保学员获得护理各种血管疾病所需的知识和临床经验。临床计划分为两个部分：一个专为一般血管医学培训而设计，另一个专为血管内专家量身定制。研究部分将确保这些临床医生培养进行独立临床研究的技能和能力。研究培训的各个要素包括研讨会和会议的教学计划、波士顿大学公共卫生学院硕士学位课程的完成以及监督研究项目。该指导研究项目将在血管相关领域的资深且经验丰富的研究人员的指导下进行。我们相信，波士顿大学医学中心凭借该领域许多知名的研究人员和项目的优势，提供了一个优秀而丰富的环境，可以培训未来的血管医学临床科学家。我们整合了这种方法，利用了我们共享的设施和资源。我们希望我们的计划能够促进对研究过程所有步骤的深入了解，从研究设计和资助到分析和出版。该计划完成后，我们希望学员能够展示血管疾病护理临床方面的专业知识，并能够很好地进行独立资助的血管研究，这两个属性被认为对该计划的成功至关重要。 （摘要完）

项目成果

An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes.

• DOI: 10.1161/jaha.113.000136
• 发表时间: 2013-10-23
• 期刊: Journal of the American Heart Association
• 影响因子: 5.4
• 作者: Cove CL;Hylek EM
• 通讯作者: Hylek EM

Therapeutic Potential of Modulating MicroRNA in Peripheral Artery Disease.

• DOI: 10.2174/15701611113119990014
• 发表时间: 2015
• 期刊: Current vascular pharmacology
• 影响因子: 4.5
• 作者: Hamburg NM;Leeper NJ
• 通讯作者: Leeper NJ

Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling.

• DOI: 10.1016/j.atherosclerosis.2016.01.043
• 发表时间: 2016-04
• 期刊: Atherosclerosis
• 影响因子: 5.3
• 作者: Fetterman JL;Holbrook M;Flint N;Feng B;Bretón-Romero R;Linder EA;Berk BD;Duess MA;Farb MG;Gokce N;Shirihai OS;Hamburg NM;Vita JA
• 通讯作者: Vita JA

Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulants.

• DOI: 10.1016/j.ahj.2016.08.017
• 发表时间: 2017-03
• 期刊: American heart journal
• 影响因子: 4.8
• 作者: Fanola CL;Mooney D;Cowan AJ;Ko D;Sisson EK;Henault LE;Tripodis Y;Hylek EM
• 通讯作者: Hylek EM

Biomarkers in lone atrial fibrillation - an additional 'fine tuning' of risk?

孤立性心房颤动的生物标志物——风险的额外“微调”？

• DOI: 10.2174/1381612820666140825131744
• 发表时间: 2015
• 期刊: Current pharmaceutical design
• 影响因子: 3.1
• 作者: Ko,Darae;Magnani,JaredW;Hylek,ElaineM
• 通讯作者: Hylek,ElaineM